News

May 22, 2018May 22, 2018

Impaired Visual Response to Blue Light May Be Linked to Non-Motor Symptoms

News

Parkinson’s disease is linked to impaired response of eyes to blue light, a finding that may provide new insights into the mechanisms involved in non-motor symptoms of the disease. The ... Read more

May 22, 2018May 22, 2018

Working Memory Impairment Occurs Before Cognitive Decline, Study Finds

News

The inability to remember proper sequences of information, such as numbers or events, occurs before cognitive impairment in Parkinson’s patients who have mild motor symptoms, a Chinese study shows. The ... Read more

May 21, 2018May 21, 2018

Gut Microbes Linked to Progression of Neurodegenerative Disorders, Study Finds

News

Microorganisms living in the gut can influence the progression of neurodegenerative diseases through two types of brain cells, and understanding more about how they suppress inflammation could lead to ... Read more

May 21, 2018May 21, 2018

Gene Found that Regulates Protein Aggregates in Neurodegenerative Diseases

News

A gene called Ankrd16 can prevent the harmful protein aggregates that build up in neurological disorders, including Parkinson’s disease, according to researchers. Their study, “ANKRD16 prevents neuron loss caused by an ... Read more

May 18, 2018May 18, 2018

Potential Parkinson’s Vaccine, Affitope PD01A, Safe and Possibly Effective in Long-term, Phase 1 Trial Series Finds

News

Affiris’ experimental Parkinson’s vaccine, Affitope PD01A, is safe and effectively triggers an immune response against the alpha-synuclein (aSyn) protein, data from a series of four consecutive clinical trials show. Results from ... Read more

May 18, 2018May 18, 2018

How 2 Sets Nerve Cells Interact to Control Movement Seen by Scientists Using New Tool

News

Using a new tool, researchers were able to see how two different sets of neurons interact in mice to control movement. They believe the method, called spectrally resolved fiber ... Read more

May 17, 2018May 17, 2018

Affected Cell Type May Explain Differences in Parkinson’s-related Diseases, Study Suggests

News

Different brain cells determine which form of alpha-synuclein will be responsible for different Parkinson’s-related disorders, a new study suggests. The research, “Cellular milieu imparts distinct pathological α-synuclein strains in α-synucleinopathies,” was ... Read more

May 17, 2018May 17, 2018

Parkinson’s Researchers Unravel How Toxic Alfa-synuclein Affects Memory Nerve Cells

News

Scientists are closer to understanding how toxic alpha-synuclein (α-syn) aggregates affect the nerve cells involved in memory, which may point to new therapeutic strategies to prevent the development of ... Read more

May 16, 2018May 16, 2018

Enzyme Tied to Inflammation and Progression in Parkinson’s May Hold Key to Treatment, Study Says

News

Blocking an enzyme associated with inflammation and disease progression in Parkinson’s patients may by a promising way of treating this neurodegenerative disorder, new research suggests. The study, “Soluble epoxide ... Read more

May 16, 2018May 16, 2018

Alnylam’s RNAi Therapy for Parkinson’s Disease Fares Well in Rat Model

News

Alnylam’s small RNA interference (RNAi) therapies were delivered successfully to the brain and spinal cord of a rat model, bringing promise to the treatment of neurodegenerative diseases, including Parkinson’s. The company ... Read more

Pin It on Pinterest